story of the week
Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF
Diabetes Care 2020 Dec 18;[EPub Ahead of Print], SE Inzucchi, KF Docherty, L Køber, MN Kosiborod, FA Martinez, P Ponikowski, MS Sabatine, SD Solomon, S Verma, J Bělohlávek, M Böhm, CE Chiang, RA de Boer, M Diez, A Dukát, CEA Ljungman, O Bengtsson, AM Langkilde, M Sjöstrand, PS Jhund, JJV McMurrayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.